Melanocortin 1 receptor variants, pigmentation, and skin cancer susceptibility

Photodermatology Photoimmunology and Photomedicine

Volumn 20, Issue 6, 2004, Pages 283-288

  Healy, Eugene ^a,b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Melanin; Melanocortin 1 receptor; Melanoma; Skin cancer; Skin pigmentation

Indexed keywords

ALPHA INTERMEDIN; CYCLIC AMP; DNA; GUANINE NUCLEOTIDE BINDING PROTEIN; MELANIN; MELANOCORTIN 1 RECEPTOR;

ALLELE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CELL TYPE; DNA STRAND BREAKAGE; ENZYME ACTIVATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAIR COLOR; HUMAN; MELANOCYTE; MELANOMA CELL; NONHUMAN; PHENOTYPE; PIGMENT DISORDER; POPULATION GENETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN CANCER; SKIN CELL; SKIN COLOR; SOMATIC MUTATION; TRANSCRIPTION INITIATION SITE;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; MELANOMA; RECEPTOR, MELANOCORTIN, TYPE 1; SKIN NEOPLASMS; SKIN PIGMENTATION;

EID: 9444281498     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2004.00132.x     Document Type: Review

References (63)

1. Gantz I, Fong TM. The melanocortin system. Am J Physiol Endocrinol Metab 2003; 284: E468-E474.
2. Adachi S, Nakano T, Vliagoftis H, Metcalfe DD. Receptor-mediated modulation of murine mast cell function by alpha-melanocyte stimulating hormone. J Immunol 1999; 163: 3363-3368.
3. Bhardwaj R, Becher E, Mahnke K, et al. Evidence for the differential expression of the functional alpha-melanocyte-stimulating hormone receptor MC-1 on human monocytes. J Immunol 1997; 158: 3378-3384.
4. Bohm M, Metze D, Schulte U, Becher E, Luger TA, Brzoska T. Detection of melanocortin-1 receptor antigenicity on human skin cells in culture and in situ. Exp Dermatol 1999; 8: 453-461.
5. Bohm M, Schiller M, Stander S, et al. Evidence for expression of melanocortin-1 receptor in human sebocytes in vitro and in situ. J Invest Dermatol 2002; 118: 533-539.
6. Bohm M, Raghunath M, Sunderkotter C, et al. Collagen metabolism is a novel target of the neuropeptide alpha-melanocyte-stimulating hormone. J Biol Chem 2004; 279: 6959-6966.
7. Grutzkau A, Henz BM, Kirchhof L, Luger T, Artuc M. Alpha-melanocyte stimulating hormone acts as a selective inducer of secretory functions in human mast cells. Biochem Biophys Res Commun 2000; 278: 14-19.
8. Hartmeyer M, Scholzen T, Becher E, Bhardwaj RS, Schwarz T, Luger TA. Human dermal microvascular endothelial cells express the melanocortin receptor type 1 and produce increased levels of IL-8 upon stimulation with alpha-melanocyte-stimulating hormone. J Immunol 1997; 159: 1930-1937.
9. Salazar-Onfray F, Lopez M, Lundqvist A, et al. Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker. Br J Cancer 2002; 87: 414-422.
10. Stander S, Bohm M, Brzoska T, Zimmer KP, Luger T, Metze D. Expression of melanocortin-1 receptor in normal, malformed and neoplastic skin glands and hair follicles. Exp Dermatol 2002; 11: 42-51.
11. Xia Y, Wikberg JE, Chhajlani V. Expression of melanocortin 1 receptor in periaqueductal gray matter. Neuroreport 1995; 6: 2193-2196.
12. Elliott RJ, Szabo M, Wagner MJ, Kemp EH, MacNeit S, Haycock JW. Alpha-melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells. J Invest Dermatol 2004; 122: 1010-1019.
13. Mountjoy KG, Kong PL, Taylor JA, Willard DH, Wilkison WO. Melanocortin receptor-mediated mobilization of intracellular free calcium in HEK293 cells. Physiol Genom 2001; 5: 11-19.
14. Bertolotto C, Abbe P, Hemesath TJ, et al. Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J Cell Biol 1998; 142: 827-835.
15. Bertolotto C, Busca R, Abbe P, et al. Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: pivotal role of M boxes (GTCATGTGCT) and of microphthalmia. Mol Cell Biol 1998; 18: 694-702.
16. Ozeki H, Ito S, Wakamatsu K, Hirobe T. Chemical characterization of hair melanins in various coat-color mutants of mice. J Invest Dermatol 1995; 105: 361-366.
17. Wilson BD, Ollmann MM, Kang L, Stoffel M, Bell GI, Barsh GS. Structure and function of ASP, the human homolog of the mouse agouti gene. Hum Mol Genet 1995; 4: 223-230.
18. Lu D, Willard D, Patel IR, et al. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 1994; 371: 799-802.
19. Millar SE, Miller MW, Stevens ME, Barsh GS. Expression and transgenic studies of the mouse agouti gene provide insight into the mechanisms by which mammalian coat color patterns are generated. Development 1995; 121: 3223-3232.
20. Kanetsky PA, Swoyer J, Panossian S, Holmes R, Guerry D, Rebbeck TR. A polymorphism in the agouti signaling protein gene is associated with human pigmentation. Am J Hum Genet 2002; 70: 770-775.
21. Voisey J, Box NF, van Daal A. A polymorphism study of the human Agouti gene and its association with MC1R. Pigment Cell Res 2001; 14: 264-267.
22. Yaswen L, Diehl N, Brennan MB, Hochgeschwender U. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med 1999; 5: 1066-1070.
23. Healy E, Jordan SA, Budd PS, Suffolk R, Rees JL, Jackson IJ. Functional variation of MC1R alleles from red-haired individuals. Hum Mol Genet 2001; 10: 2397-2402.
24. Robbins LS, Nadeau JH, Johnson KR, et al. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 1993; 72: 827-834.
25. Flanagan N, Healy E, Ray A, et al. Pleiotropic effects of the melanocortin 1 receptor (MC1R) gene on human pigmentation. Hum Mol Genet 2000; 9: 2531-2537.
26. Healy E, Flannagan N, Ray A, et al. Melanocortin-l-receptor gene and sun sensitivity in individuals without red hair. Lancet 2000; 355: 1072-1073.
27. Harding RM, Healy E, Ray AJ, et al. Evidence for variable selective pressures at MC1R. Am J Hum Genet 2000; 66: 1351-1361.
28. Bastiaens M, ter Huurne J, Gruis N, et al. The melanocortin-1-receptor gene is the major freckle gene. Hum Mol Genet 2001; 10: 1701-1708.
29. Fargnoli MC, Chimenti S, Keller G, Hofler H, Peris K. Identification of four novel melanocortin 1 receptor (MC1R) gene variants in a Mediterranean population. Hum Mutat 2003; 21: 655.
30. John PR, Makova K, Li W H, Jenkins T, Ramsay M. DNA polymorphism and selection at the melanocortin-1 receptor gene in normally pigmented southern African individuals. Ann NY Acad Sci 2003; 994: 299-306.
31. Rana BK, Hewett-Emmett D, Jin L, et al. High polymorphism at the human melanocortin 1 receptor locus. Genetics 1999; 151: 1547-1557.
32. Valverde P, Healy E, Jackson I, Rees JL, Thody AJ. Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet 1995; 11: 328-330.
33. King RA, Willaert RK, Schmidt RM, et al. MC1R mutations modify the classic phenotype of oculocutaneous albinism type 2 (OCA2). Am J Hum Genet 2003; 73: 638-645.
34. McKenzie CA, Harding RM, Tomlinson JB, Ray AJ, Wakamatsu K, Rees JL. Phenotypic expression of melanocortin-1 receptor mutations in Black Jamaicans. J Invest Dermatol 2003; 121: 207-208.
35. Jimenez-Cervantes C, Germer S, Gonzalez P, Sanchez J, Sanchez CO, Garcia-Borron JC. Thr40 and Met122 are new partial loss-of-function natural mutations of the human melanocortin 1 receptor. FEBS Lett 2001; 508: 44-48.
36. Jimenez-Cervantes C, Olivares C, Gonzalez P, Morandini R, Ghanem G, Garcia-Borron JC. The Pro162 variant is a loss-of-function mutation of the human melanocortin 1 receptor gene. J Invest Dermatol 2001; 117: 156-158.
37. Robinson SJ, Healy E. Human melanocortin 1 receptor (MC1R) gene variants alter melanoma cell growth and adhesion to extracellular matrix. Oncogene 2002; 21: 80378046.
38. Sanchez MJ, Olivares SC, Ghanem G, et al. Loss-of-function variants of the human melanocortin-1 receptor gene in melanoma cells define structural determinants of receptor function. Eur J Biochem 2002; 269: 6133-6141.
39. Schioth HB, Phillips SR, Rudzish R, Birch-Machin MA, Wikberg JE, Rees JL. Loss of function mutations of the human melanocortin 1 receptor are common and are associated with red hair. Biochem Biophys Res Commun 1999; 260: 488-491.
40. Smith R, Healy E, Siddiqui S, et al. Melanocortin 1 receptor variants in an Irish population. J Invest Dermatol 1998; 111: 119-122.
41. Makova KD, Ramsay M, Jenkins T, Li WH. Human DNA sequence variation in a 6.6-kb region containing the melanocortin 1 receptor promoter. Genetics 2001; 158: 1253-1268.
42. Box NF, Wyeth JR, O'Gorman LE, Martin NG, Sturm RA. Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair. Hum Mol Genet 1997; 6: 1891-1897.
43. Duffy DL, Box NF, Chen W, et al. Interactive effects of MC1R and OCA2 on melanoma risk phenotypes. Hum Mol Genet 2004; 13: 447-461.
44. Bastiaens MT, ter Huurne JA, Kielich C, et al. Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. Am J Hum Genet 2001; 68: 884-894.
45. Box NF, Duffy DL, Irving RE, et al. Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma. J Invest Dermatol 2001; 116: 224-229.
46. Kennedy C, ter Huurne J, Berkhout M, et al. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 2001; 117: 294-300.
47. Matichard E, Verpillat P, Meziani R, et al. Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure. J Med Genet 2064; 41: 13.
48. Palmer JS, Duffy DL, Box NF, et al. Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet 2000; 66: 176-186.
49. Valverde P, Healy E, Sikkink S, et al. The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma. Hum Mol Genet 1996; 5: 1663-1666.
50. Box NF, Duffy DL, Chen W, et al. MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am J Hum Genet 2001; 69: 765-773.
51. van der Velden PA, Sandkuijl LA, Bergman W, et al. Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma. Am J Hum Genet 2001; 69: 774-779.
52. Rampen FH, Fleuren BA, de Boo TM, Lemmens WA. Unreliability of self-reported burning tendency and tanning ability. Arch Dermatol 1988; 124: 885-888.
53. Weinstock MA, Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE. Recall (report) bias and reliability in the retrospective assessment of melanoma risk. Am J Epidemiol 1991; 133: 240-245.
54. Solca FF, Chluba-de Tapia J, Iwata K, Eberle AN. B16-G4F mouse melanoma cells: an MSH receptor-deficient cell clone. FEBS Lett 1993; 322: 177-180.
55. Chluba-de Tapia J, Bagutti C, Cotti R, Eberle AN. Induction of constitutive melanogenesis in amelanotic mouse melanoma cells by transfection of the human melanocortin-1 receptor gene. J Cell Sci 1996; 109 (Part 8): 2023-2030.
56. Ghanem G, Lienard D, Hanson P, Lejeune F, Fruhling J. Increased serum alpha-melanocyte stimulating hormone (alpha-MSH) in human malignant melanoma. Eur J Cancer Clin Oncol 1986; 22: 535-536.
57. Loir B, Sales F, Deraemaecker R, Morandini R, Garcia-Borron JC, Ghanem G. Alpha-melanotropin immunoreactivity in human melanoma exudate is related to necrosis. Eur J Cancer 1998; 34: 424-426.
58. Lunec J, Pieron C, Sherbet GV, Thody AJ. Alpha-melanocyte-stimulating hormone immunoreactivity in melanoma cells. Pathobiology 1990; 58: 193-197.
59. Hunt G, Kyne S, Ito S, Wakamatsu K, Todd C, Thody A. Eumelanin and phaeomelanin contents of human epidermis and cultured melanocytes. Pigment Cell Res 1995; 8: 202-208.
60. Menon IA, Persad S, Ranadive NS, Haberman HF. Effects of ultraviolet-visible irradiation in the presence of melanin isolated from human black or red hair upon Ehrlich ascites carcinoma cells. Cancer Res 1983; 43: 3165-3169.
61. Menon IA, Persad S, Haberman HF, Kurian CJ. A comparative study of the physical and chemical properties of melanins isolated from human black and red hair. J Invest Dermatol 1983; 80: 202-206.
62. Menon IA, Persad S, Ranadive NS, Haberman HF. Role of superoxide and hydrogen peroxide in cell lysis during irradiation in vitro of Ehrlich ascitic carcinoma cells in the presence of melanin. Can J Biochem Cell Biol 1985; 63: 278-283.
63. Persad S, Menon IA, Haberman HF. Comparison of the effects of UV-visible irradiation of melanins and melanin-hematoporphyrin complexes from human black and red hair. Photochem Photobiol 1983; 37: 63-68.